Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.

Ashwin Jaikumarr RamSmiline Girija AsVijayashree Priyadharsini Jayaseelan

Published in: Asian Pacific journal of cancer prevention : APJCP (2020)

These findings suggest that BASP1 was frequently amplified which contributes to the overexpression of BASP1, thereby promoting HNSCC progression. Thus, these results indicate that BASP1 might serve as a biomarker to predict the progression and prognosis of HNSCC patients.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
cell proliferation
ejection fraction
newly diagnosed
peritoneal dialysis
transcription factor
patient reported outcomes